Baird Financial Group, Inc. Incyte Corp Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
A detailed history of Baird Financial Group, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 154,057 shares of INCY stock, worth $13.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
154,057
Previous 147,064
4.76%
Holding current value
$13.2 Million
Previous $8.9 Million
17.82%
% of portfolio
0.02%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding INCY
# of Institutions
732Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.62 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.82 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.72 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.25 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$843 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...